What Researchers Did
Researchers conducted a randomized controlled trial to assess if hyperbaric oxygen therapy, in addition to standard care, improved limb salvage and wound healing in diabetic patients with ischemic leg ulcers.
What They Found
After 12 months, limb salvage was achieved in 47 patients in the standard care group versus 53 in the hyperbaric oxygen therapy (HBOT) group, with a risk difference of 10%. Complete wound healing occurred in 28 standard care patients compared to 30 HBOT patients, showing a risk difference of 3%. Overall, additional HBOT did not significantly improve complete wound healing or limb salvage.
What This Means for Canadian Patients
For Canadian patients with diabetes and ischemic leg ulcers, this study suggests that adding hyperbaric oxygen therapy to standard care may not significantly improve wound healing or prevent limb amputation. Patients should discuss with their healthcare providers whether the potential benefits of HBOT outweigh the burden of treatment, given these findings.
Canadian Relevance
This study was not conducted in Canada and therefore its direct relevance to the Canadian healthcare system or patient population is not explicitly established.
Study Limitations
A notable limitation was that 35% of patients in the hyperbaric oxygen therapy group were unable to complete the treatment protocol as planned.